Trial site
Gyöngyösi Bugát Pál Kórház
- 9running trials
- 13closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Atopic dermatitis (eczema)4 trials
- Heart failure3 trials
- Ulcerative colitis3 trials
- Crohn's disease2 trials
- Depression2 trials
- Mild cognitive impairment2 trials
- Obesity2 trials
- Schizophrenia2 trials
- Liver cirrhosis1 trial
- Migraine1 trial
- Psoriasis1 trial
- Phase
- Phase 314 trials
- Phase 27 trials
- Phase 41 trial
- Status
- Completed13 trials
- Active, not recruiting5 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- AbbVie4 trials
- Abivax S.A.2 trials
- Amgen2 trials
- Janssen Cilag International2 trials
- Janssen Research & Development, LLC2 trials
- and 8 more
Running trials
Enrolling by invitation
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Schizophrenia2 recruiting
- Crohn's disease1 recruiting
- Heart failure1 recruiting
- Obesity1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
A study to test whether BI 706321 combined with ustekinumab helps people with Crohn's Disease
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
Completed
Acute-On-Chronic Liver Failure (ACLF) at High Risk of Hospital Mortality
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 13 Nov 2026